If that's the line of thinking, we know that the independent parties who HAVE seen the data have turned MSB down multiple times - the FDA and Novartis.
A look under the hood was all it took for Novartis. Wonder why?
And the FDA can support pathways for accelerated approval all day. The real money is actually getting approval, so we can chat about that when it happens hey?
Ann: FDA Supports Accelerated Approval Pathway for Heart Failure, page-428
-
- There are more pages in this discussion • 122 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
99.0¢ |
Change
0.010(1.02%) |
Mkt cap ! $1.130B | |||
| Open | High | Low | Value | Volume |
| 99.5¢ | $1.02 | 98.5¢ | $5.507M | 5.501M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 9996 | 99.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 99.5¢ | 18069 | 3 |
View Market Depth
| Last trade - 16.10pm 28/06/2024 (20 minute delay) ? |
| MSB (ASX) Chart |